Does APIXABAN Cause Therapy interrupted? 395 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 395 reports of Therapy interrupted have been filed in association with APIXABAN (ELIQUIS). This represents 0.3% of all adverse event reports for APIXABAN.
395
Reports of Therapy interrupted with APIXABAN
0.3%
of all APIXABAN reports
8
Deaths
162
Hospitalizations
How Dangerous Is Therapy interrupted From APIXABAN?
Of the 395 reports, 8 (2.0%) resulted in death, 162 (41.0%) required hospitalization, and 24 (6.1%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 395 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which APIXABAN Alternatives Have Lower Therapy interrupted Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ